![The intracellular mechanisms in a smooth muscle cell after sumatriptan,... | Download Scientific Diagram The intracellular mechanisms in a smooth muscle cell after sumatriptan,... | Download Scientific Diagram](https://www.researchgate.net/publication/322898573/figure/fig2/AS:669212079030298@1536564001814/The-intracellular-mechanisms-in-a-smooth-muscle-cell-after-sumatriptan-cilostazol-and_Q320.jpg)
The intracellular mechanisms in a smooth muscle cell after sumatriptan,... | Download Scientific Diagram
![The intracellular mechanisms in a smooth muscle cell after sumatriptan,... | Download Scientific Diagram The intracellular mechanisms in a smooth muscle cell after sumatriptan,... | Download Scientific Diagram](https://www.researchgate.net/publication/322898573/figure/fig2/AS:669212079030298@1536564001814/The-intracellular-mechanisms-in-a-smooth-muscle-cell-after-sumatriptan-cilostazol-and.png)
The intracellular mechanisms in a smooth muscle cell after sumatriptan,... | Download Scientific Diagram
![Ph. Wafa Bin Shamlan ☤ ⌬ on Twitter: "#Contraindications Ischemic coronary artery disease •Wolff-Parkinson-White syndrome •History of stroke or (TIA) •Peripheral vascular disease •Uncontrolled hypertension •Recent use of ergot-type medication ... Ph. Wafa Bin Shamlan ☤ ⌬ on Twitter: "#Contraindications Ischemic coronary artery disease •Wolff-Parkinson-White syndrome •History of stroke or (TIA) •Peripheral vascular disease •Uncontrolled hypertension •Recent use of ergot-type medication ...](https://pbs.twimg.com/media/ESzwABaXQAEpTHf.jpg)
Ph. Wafa Bin Shamlan ☤ ⌬ on Twitter: "#Contraindications Ischemic coronary artery disease •Wolff-Parkinson-White syndrome •History of stroke or (TIA) •Peripheral vascular disease •Uncontrolled hypertension •Recent use of ergot-type medication ...
![An overview of mechanisms/actions of antimigraine drugs on perivascular... | Download Scientific Diagram An overview of mechanisms/actions of antimigraine drugs on perivascular... | Download Scientific Diagram](https://www.researchgate.net/publication/321709988/figure/fig1/AS:614093379624984@1523422679208/An-overview-of-mechanisms-actions-of-antimigraine-drugs-on-perivascular-CGRPergic.png)
An overview of mechanisms/actions of antimigraine drugs on perivascular... | Download Scientific Diagram
![Identifying New Antimigraine Targets: Lessons from Molecular Biology: Trends in Pharmacological Sciences Identifying New Antimigraine Targets: Lessons from Molecular Biology: Trends in Pharmacological Sciences](https://www.cell.com/cms/asset/a327bab8-1ae8-4299-885c-97df0a02df3c/gr1.jpg)
Identifying New Antimigraine Targets: Lessons from Molecular Biology: Trends in Pharmacological Sciences
![Lasmiditan mechanism of action – review of a selective 5-HT1F agonist | The Journal of Headache and Pain | Full Text Lasmiditan mechanism of action – review of a selective 5-HT1F agonist | The Journal of Headache and Pain | Full Text](https://media.springernature.com/lw685/springer-static/image/art%3A10.1186%2Fs10194-020-01132-3/MediaObjects/10194_2020_1132_Fig2_HTML.png)
Lasmiditan mechanism of action – review of a selective 5-HT1F agonist | The Journal of Headache and Pain | Full Text
![Beyond its anti‐migraine properties, sumatriptan is an anti‐inflammatory agent: A systematic review - Ala - 2021 - Drug Development Research - Wiley Online Library Beyond its anti‐migraine properties, sumatriptan is an anti‐inflammatory agent: A systematic review - Ala - 2021 - Drug Development Research - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/8a0f8c64-fa12-4f12-9145-9c92c0d6c3d4/ddr21819-fig-0002-m.jpg)
Beyond its anti‐migraine properties, sumatriptan is an anti‐inflammatory agent: A systematic review - Ala - 2021 - Drug Development Research - Wiley Online Library
![Pathophysiological Mechanisms in Migraine and the Identification of New Therapeutic Targets | SpringerLink Pathophysiological Mechanisms in Migraine and the Identification of New Therapeutic Targets | SpringerLink](https://media.springernature.com/lw685/springer-static/image/art%3A10.1007%2Fs40263-019-00630-6/MediaObjects/40263_2019_630_Fig1_HTML.png)